microRNA information: hsa-miR-542-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-542-3p | miRbase |
Accession: | MIMAT0003389 | miRbase |
Precursor name: | hsa-mir-542 | miRbase |
Precursor accession: | MI0003686 | miRbase |
Symbol: | MIR542 | HGNC |
RefSeq ID: | NR_030399 | GenBank |
Sequence: | UGUGACAGAUUGAUAACUGAAA |
Reported expression in cancers: hsa-miR-542-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-542-3p | bladder cancer | deregulation | "To investigate the clinical significance of microR ......" | 26723509 | qPCR |
hsa-miR-542-3p | esophageal cancer | downregulation | "Decreased expression of miR 542 3p exerts growth i ......" | 26323919 | qPCR |
hsa-miR-542-3p | gastric cancer | downregulation | "Here we report on miR-542-3p in gastric cancers wh ......" | 25432696 | qPCR |
hsa-miR-542-3p | melanoma | downregulation | "miR-542-3p has been characterized as a tumor suppr ......" | 27107696 |
Reported cancer pathway affected by hsa-miR-542-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-542-3p | bladder cancer | cell cycle pathway | "MicroRNA 542 3p suppresses cellular proliferation ......" | 26723509 | Flow cytometry; Colony formation |
hsa-miR-542-3p | breast cancer | Apoptosis pathway | "Hyaluronic acid coated PEI PLGA nanoparticles medi ......" | 26711968 | |
hsa-miR-542-3p | breast cancer | cell cycle pathway | "We demonstrate that resveratrol regulates apoptoti ......" | 26890143 | |
hsa-miR-542-3p | colorectal cancer | Apoptosis pathway | "miR 542 3p inhibits the growth and invasion of col ......" | 26952924 | Luciferase; Cell proliferation assay; Cell migration assay; Cell Proliferation Assay |
hsa-miR-542-3p | melanoma | Epithelial mesenchymal transition pathway | "miR 542 3p suppresses invasion and metastasis by t ......" | 27107696 | Western blot; Luciferase |
Reported cancer prognosis affected by hsa-miR-542-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-542-3p | bladder cancer | malignant trasformation; progression | "MicroRNA 542 3p suppresses cellular proliferation ......" | 26723509 | Flow cytometry; Colony formation |
hsa-miR-542-3p | breast cancer | drug resistance | "We demonstrate that resveratrol regulates apoptoti ......" | 26890143 | |
hsa-miR-542-3p | colorectal cancer | metastasis | "EpCAM+ bone marrow cells were collected using immu ......" | 24448820 | |
hsa-miR-542-3p | melanoma | metastasis; cell migration | "miR 542 3p suppresses invasion and metastasis by t ......" | 27107696 | Western blot; Luciferase |
hsa-miR-542-3p | prostate cancer | drug resistance | "To screen for epigenetically silenced miRNAs in pr ......" | 22310291 | |
hsa-miR-542-3p | sarcoma | tumorigenesis | "MiR 542 5p is a negative prognostic factor and pro ......" | 26498360 |
Reported gene related to hsa-miR-542-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-542-3p | colorectal cancer | CTTN | "miR 542 3p inhibits the growth and invasion of col ......" | 26952924 |
hsa-miR-542-3p | sarcoma | HUWE1 | "MiR 542 5p is a negative prognostic factor and pro ......" | 26498360 |
hsa-miR-542-3p | melanoma | MAP3K14 | "miR 542 3p suppresses invasion and metastasis by t ......" | 27107696 |
hsa-miR-542-3p | gastric cancer | MTDH | "Notably overexpression of miR-542-3p apparently re ......" | 25432696 |
hsa-miR-542-3p | melanoma | PIM1 | "miR 542 3p suppresses invasion and metastasis by t ......" | 27107696 |
hsa-miR-542-3p | breast cancer | TP53 | "Intracellular restoration of miR-542-3p further pr ......" | 26711968 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-542-3p | RIC3 | 10 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD | MirTarget; PITA; miRNATAP | TCGA BLCA -0.505; TCGA COAD -0.736; TCGA HNSC -0.264; TCGA KIRC -0.436; TCGA KIRP -0.165; TCGA LGG -0.138; TCGA LUAD -0.31; TCGA PRAD -0.111; TCGA SARC -0.643; TCGA STAD -0.673 |
hsa-miR-542-3p | FYCO1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; SARC; STAD | MirTarget; miRanda; miRNATAP | TCGA BLCA -0.181; TCGA BRCA -0.135; TCGA COAD -0.231; TCGA ESCA -0.389; TCGA HNSC -0.181; TCGA KIRC -0.144; TCGA LUAD -0.082; TCGA SARC -0.312; TCGA STAD -0.427 |
hsa-miR-542-3p | ARHGAP5 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; PRAD; SARC; STAD | MirTarget; PITA; miRanda; miRNATAP | TCGA BLCA -0.093; TCGA BRCA -0.151; TCGA COAD -0.107; TCGA ESCA -0.156; TCGA HNSC -0.1; TCGA KIRC -0.128; TCGA LGG -0.077; TCGA PRAD -0.052; TCGA SARC -0.061; TCGA STAD -0.162 |
hsa-miR-542-3p | SLC48A1 | 10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; SARC; STAD | MirTarget; miRanda; miRNATAP | TCGA BLCA -0.086; TCGA BRCA -0.063; TCGA HNSC -0.141; TCGA KIRC -0.253; TCGA LGG -0.102; TCGA LIHC -0.07; TCGA LUAD -0.115; TCGA PAAD -0.197; TCGA SARC -0.131; TCGA STAD -0.251 |
hsa-miR-542-3p | TPPP | 9 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUAD; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.334; TCGA COAD -0.325; TCGA ESCA -0.277; TCGA HNSC -0.314; TCGA LGG -0.178; TCGA LUAD -0.153; TCGA PAAD -0.381; TCGA SARC -0.719; TCGA STAD -0.307 |
hsa-miR-542-3p | STIM1 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LIHC; SARC; STAD | PITA; miRNATAP | TCGA BLCA -0.122; TCGA BRCA -0.122; TCGA COAD -0.065; TCGA HNSC -0.134; TCGA KIRC -0.071; TCGA LGG -0.077; TCGA LIHC -0.11; TCGA SARC -0.072; TCGA STAD -0.253 |
hsa-miR-542-3p | HIF1AN | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; STAD | PITA; miRanda | TCGA BLCA -0.068; TCGA BRCA -0.069; TCGA CESC -0.103; TCGA COAD -0.07; TCGA ESCA -0.087; TCGA HNSC -0.058; TCGA KIRC -0.054; TCGA LIHC -0.163; TCGA LUAD -0.074; TCGA PAAD -0.091; TCGA STAD -0.078 |
hsa-miR-542-3p | CTDSPL | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LUAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.11; TCGA BRCA -0.075; TCGA COAD -0.096; TCGA ESCA -0.221; TCGA KIRC -0.193; TCGA LGG -0.086; TCGA LUAD -0.143; TCGA SARC -0.084; TCGA THCA -0.062; TCGA STAD -0.135 |
hsa-miR-542-3p | SLMAP | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; SARC; STAD | miRanda | TCGA BLCA -0.221; TCGA BRCA -0.149; TCGA COAD -0.153; TCGA ESCA -0.327; TCGA HNSC -0.091; TCGA KIRC -0.198; TCGA LUAD -0.057; TCGA SARC -0.493; TCGA STAD -0.501 |
hsa-miR-542-3p | CPEB3 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.194; TCGA BRCA -0.143; TCGA ESCA -0.257; TCGA HNSC -0.429; TCGA KIRC -0.19; TCGA LGG -0.255; TCGA LUAD -0.119; TCGA PAAD -0.125; TCGA SARC -0.053; TCGA STAD -0.195 |
hsa-miR-542-3p | CALCOCO2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.112; TCGA BRCA -0.157; TCGA ESCA -0.113; TCGA HNSC -0.084; TCGA LGG -0.108; TCGA LIHC -0.073; TCGA PAAD -0.105; TCGA SARC -0.061; TCGA STAD -0.071 |
hsa-miR-542-3p | TLE4 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.192; TCGA COAD -0.23; TCGA HNSC -0.162; TCGA KIRC -0.164; TCGA KIRP -0.099; TCGA LUAD -0.128; TCGA SARC -0.083; TCGA THCA -0.086; TCGA STAD -0.238 |
hsa-miR-542-3p | CDC42BPA | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.208; TCGA BRCA -0.092; TCGA COAD -0.154; TCGA ESCA -0.173; TCGA KIRC -0.093; TCGA LIHC -0.11; TCGA PAAD -0.127; TCGA SARC -0.067; TCGA STAD -0.134 |
hsa-miR-542-3p | ZMIZ1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; STAD | miRanda | TCGA BLCA -0.081; TCGA BRCA -0.099; TCGA COAD -0.129; TCGA ESCA -0.111; TCGA HNSC -0.142; TCGA LGG -0.086; TCGA LUAD -0.189; TCGA LUSC -0.223; TCGA STAD -0.139 |
hsa-miR-542-3p | MLLT6 | 10 cancers: BLCA; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC | miRanda | TCGA BLCA -0.098; TCGA ESCA -0.207; TCGA HNSC -0.136; TCGA KIRP -0.086; TCGA LGG -0.057; TCGA LIHC -0.173; TCGA LUAD -0.108; TCGA PAAD -0.092; TCGA PRAD -0.095; TCGA SARC -0.168 |
hsa-miR-542-3p | VWA5A | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUAD; PAAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.288; TCGA ESCA -0.254; TCGA HNSC -0.191; TCGA KIRC -0.19; TCGA LUAD -0.1; TCGA PAAD -0.169; TCGA SARC -0.164; TCGA THCA -0.132; TCGA STAD -0.175 |
hsa-miR-542-3p | HDAC4 | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; PRAD; SARC; STAD | miRanda; mirMAP | TCGA BLCA -0.151; TCGA COAD -0.152; TCGA ESCA -0.143; TCGA HNSC -0.171; TCGA LGG -0.132; TCGA LIHC -0.151; TCGA LUAD -0.116; TCGA PRAD -0.066; TCGA SARC -0.059; TCGA STAD -0.307 |
hsa-miR-542-3p | GCOM1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.231; TCGA BRCA -0.153; TCGA ESCA -0.639; TCGA HNSC -0.464; TCGA KIRC -0.663; TCGA LUAD -0.377; TCGA SARC -0.138; TCGA THCA -0.225; TCGA STAD -0.26 |
hsa-miR-542-3p | SERPINB8 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; THCA | miRanda | TCGA BLCA -0.251; TCGA BRCA -0.088; TCGA CESC -0.209; TCGA COAD -0.174; TCGA HNSC -0.235; TCGA LUAD -0.161; TCGA LUSC -0.154; TCGA PRAD -0.06; TCGA THCA -0.087 |
hsa-miR-542-3p | WDR7 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.114; TCGA BRCA -0.127; TCGA COAD -0.187; TCGA HNSC -0.134; TCGA KIRC -0.06; TCGA LGG -0.074; TCGA LUAD -0.141; TCGA PAAD -0.137; TCGA SARC -0.083; TCGA STAD -0.13 |
hsa-miR-542-3p | SCAPER | 9 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.173; TCGA BRCA -0.117; TCGA HNSC -0.209; TCGA KIRC -0.151; TCGA LGG -0.111; TCGA LUAD -0.097; TCGA PAAD -0.132; TCGA SARC -0.202; TCGA STAD -0.142 |
hsa-miR-542-3p | MAP4 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.073; TCGA BRCA -0.082; TCGA COAD -0.098; TCGA ESCA -0.182; TCGA KIRC -0.059; TCGA LGG -0.111; TCGA LIHC -0.065; TCGA LUAD -0.061; TCGA SARC -0.068; TCGA THCA -0.1; TCGA STAD -0.179 |
hsa-miR-542-3p | PDLIM5 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; PRAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.169; TCGA BRCA -0.2; TCGA COAD -0.096; TCGA ESCA -0.106; TCGA HNSC -0.112; TCGA KIRC -0.096; TCGA LGG -0.125; TCGA PRAD -0.129; TCGA SARC -0.342; TCGA THCA -0.077; TCGA STAD -0.091 |
hsa-miR-542-3p | MRPS27 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.11; TCGA BRCA -0.077; TCGA CESC -0.101; TCGA HNSC -0.085; TCGA KIRC -0.077; TCGA LGG -0.101; TCGA LIHC -0.184; TCGA LUAD -0.065; TCGA PAAD -0.084; TCGA SARC -0.088; TCGA STAD -0.073 |
hsa-miR-542-3p | FBXO9 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LIHC; PAAD; PRAD; SARC; STAD | miRanda; miRNATAP | TCGA BLCA -0.071; TCGA BRCA -0.095; TCGA HNSC -0.121; TCGA KIRC -0.072; TCGA LIHC -0.127; TCGA PAAD -0.209; TCGA PRAD -0.062; TCGA SARC -0.078; TCGA STAD -0.084 |
hsa-miR-542-3p | TJP2 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; SARC; STAD | miRanda | TCGA BLCA -0.152; TCGA BRCA -0.139; TCGA ESCA -0.265; TCGA HNSC -0.258; TCGA KIRC -0.098; TCGA KIRP -0.08; TCGA LGG -0.209; TCGA LUAD -0.17; TCGA SARC -0.275; TCGA STAD -0.12 |
hsa-miR-542-3p | TXNIP | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; STAD | miRanda | TCGA BLCA -0.268; TCGA COAD -0.208; TCGA ESCA -0.529; TCGA HNSC -0.253; TCGA KIRC -0.111; TCGA LGG -0.086; TCGA LUAD -0.118; TCGA LUSC -0.268; TCGA STAD -0.527 |
hsa-miR-542-3p | MOAP1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUAD; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.117; TCGA BRCA -0.106; TCGA ESCA -0.156; TCGA HNSC -0.12; TCGA LGG -0.131; TCGA LUAD -0.087; TCGA PAAD -0.198; TCGA SARC -0.225; TCGA STAD -0.282 |
hsa-miR-542-3p | AFF4 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; SARC; STAD | miRanda | TCGA BLCA -0.096; TCGA BRCA -0.128; TCGA COAD -0.117; TCGA ESCA -0.169; TCGA HNSC -0.088; TCGA KIRC -0.094; TCGA LUAD -0.109; TCGA SARC -0.074; TCGA STAD -0.139 |
hsa-miR-542-3p | LNPEP | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; SARC; STAD; UCEC | miRanda | TCGA BLCA -0.166; TCGA BRCA -0.245; TCGA COAD -0.126; TCGA ESCA -0.23; TCGA HNSC -0.122; TCGA KIRC -0.296; TCGA LUAD -0.13; TCGA SARC -0.096; TCGA STAD -0.224; TCGA UCEC -0.1 |
hsa-miR-542-3p | FGD4 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; UCEC | miRanda | TCGA BLCA -0.093; TCGA BRCA -0.157; TCGA COAD -0.103; TCGA ESCA -0.41; TCGA HNSC -0.155; TCGA KIRC -0.101; TCGA LGG -0.093; TCGA LUAD -0.227; TCGA UCEC -0.087 |
hsa-miR-542-3p | PRUNE2 | 9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.302; TCGA BRCA -0.127; TCGA COAD -0.455; TCGA ESCA -1.184; TCGA LGG -0.236; TCGA LUAD -0.289; TCGA SARC -0.566; TCGA THCA -0.307; TCGA STAD -1.079 |
hsa-miR-542-3p | FBXL17 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; STAD | miRanda | TCGA BLCA -0.126; TCGA BRCA -0.127; TCGA HNSC -0.206; TCGA KIRC -0.144; TCGA LGG -0.062; TCGA LUAD -0.106; TCGA LUSC -0.084; TCGA PAAD -0.105; TCGA STAD -0.168 |
hsa-miR-542-3p | KLHL21 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; SARC; STAD | miRanda | TCGA BLCA -0.155; TCGA CESC -0.185; TCGA ESCA -0.177; TCGA HNSC -0.153; TCGA KIRC -0.157; TCGA LGG -0.072; TCGA LIHC -0.25; TCGA LUSC -0.1; TCGA SARC -0.179; TCGA STAD -0.309 |
hsa-miR-542-3p | ZNF407 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LIHC; LUAD; SARC; STAD | miRanda | TCGA BLCA -0.104; TCGA BRCA -0.074; TCGA COAD -0.19; TCGA HNSC -0.106; TCGA KIRC -0.061; TCGA LIHC -0.072; TCGA LUAD -0.146; TCGA SARC -0.072; TCGA STAD -0.111 |
hsa-miR-542-3p | TSPYL1 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; PAAD; SARC; STAD | miRanda | TCGA BLCA -0.096; TCGA BRCA -0.113; TCGA HNSC -0.059; TCGA KIRC -0.145; TCGA LGG -0.094; TCGA LUAD -0.098; TCGA PAAD -0.16; TCGA SARC -0.061; TCGA STAD -0.195 |
hsa-miR-542-3p | CASZ1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRanda | TCGA BLCA -0.183; TCGA CESC -0.207; TCGA COAD -0.171; TCGA ESCA -0.307; TCGA HNSC -0.28; TCGA LUAD -0.173; TCGA LUSC -0.194; TCGA PAAD -0.289; TCGA PRAD -0.078; TCGA SARC -0.399; TCGA STAD -0.378; TCGA UCEC -0.123 |
hsa-miR-542-3p | OSBPL2 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; UCEC | mirMAP | TCGA BLCA -0.067; TCGA BRCA -0.071; TCGA CESC -0.146; TCGA HNSC -0.135; TCGA KIRC -0.115; TCGA LGG -0.065; TCGA LIHC -0.079; TCGA LUAD -0.078; TCGA LUSC -0.118; TCGA PAAD -0.149; TCGA UCEC -0.054 |
hsa-miR-542-3p | LYNX1 | 9 cancers: BLCA; COAD; HNSC; LGG; LIHC; LUSC; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.398; TCGA COAD -0.283; TCGA HNSC -0.43; TCGA LGG -0.243; TCGA LIHC -0.185; TCGA LUSC -0.37; TCGA SARC -0.535; TCGA THCA -0.15; TCGA STAD -0.791 |
hsa-miR-542-3p | BTBD9 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LIHC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.083; TCGA COAD -0.098; TCGA ESCA -0.13; TCGA HNSC -0.131; TCGA KIRC -0.089; TCGA LIHC -0.091; TCGA PAAD -0.106; TCGA PRAD -0.093; TCGA STAD -0.073 |
hsa-miR-542-3p | LRP10 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.194; TCGA COAD -0.162; TCGA ESCA -0.179; TCGA HNSC -0.154; TCGA KIRC -0.095; TCGA LUAD -0.101; TCGA LUSC -0.128; TCGA SARC -0.099; TCGA THCA -0.072; TCGA STAD -0.176 |
hsa-miR-542-3p | HIPK3 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; SARC; STAD | miRNATAP | TCGA BLCA -0.19; TCGA BRCA -0.3; TCGA COAD -0.168; TCGA ESCA -0.24; TCGA HNSC -0.177; TCGA KIRC -0.188; TCGA LUAD -0.114; TCGA SARC -0.172; TCGA STAD -0.268 |
hsa-miR-542-3p | PARP12 | 9 cancers: BLCA; BRCA; CESC; KIRP; LIHC; LUSC; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.098; TCGA BRCA -0.062; TCGA CESC -0.124; TCGA KIRP -0.111; TCGA LIHC -0.123; TCGA LUSC -0.165; TCGA PRAD -0.062; TCGA THCA -0.085; TCGA UCEC -0.082 |
hsa-miR-542-3p | NEBL | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD | PITA; miRNATAP | TCGA BRCA -0.15; TCGA ESCA -0.414; TCGA HNSC -0.584; TCGA KIRC -0.215; TCGA KIRP -0.14; TCGA LGG -0.287; TCGA LUAD -0.148; TCGA PAAD -0.33; TCGA PRAD -0.141 |
hsa-miR-542-3p | FOXP1 | 11 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; STAD | PITA; miRanda | TCGA BRCA -0.055; TCGA COAD -0.128; TCGA ESCA -0.257; TCGA KIRC -0.103; TCGA KIRP -0.064; TCGA LGG -0.141; TCGA LIHC -0.069; TCGA LUAD -0.152; TCGA PRAD -0.107; TCGA SARC -0.124; TCGA STAD -0.174 |
hsa-miR-542-3p | ZMYND8 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; UCEC | miRanda | TCGA BRCA -0.082; TCGA CESC -0.104; TCGA ESCA -0.141; TCGA HNSC -0.14; TCGA KIRP -0.053; TCGA LIHC -0.095; TCGA LUAD -0.05; TCGA PAAD -0.17; TCGA PRAD -0.115; TCGA SARC -0.069; TCGA UCEC -0.089 |
hsa-miR-542-3p | MKRN1 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; PAAD; SARC; UCEC | miRanda | TCGA BRCA -0.073; TCGA ESCA -0.091; TCGA HNSC -0.109; TCGA KIRC -0.058; TCGA KIRP -0.077; TCGA LIHC -0.096; TCGA PAAD -0.091; TCGA SARC -0.08; TCGA UCEC -0.051 |
hsa-miR-542-3p | ATP6V0A1 | 10 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD | miRanda | TCGA BRCA -0.062; TCGA ESCA -0.177; TCGA HNSC -0.127; TCGA LGG -0.144; TCGA LIHC -0.166; TCGA LUAD -0.086; TCGA LUSC -0.08; TCGA PAAD -0.171; TCGA SARC -0.064; TCGA STAD -0.134 |
hsa-miR-542-3p | DCAF8 | 9 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUSC; PAAD; SARC; STAD | miRanda | TCGA BRCA -0.069; TCGA CESC -0.058; TCGA ESCA -0.079; TCGA LGG -0.076; TCGA LIHC -0.148; TCGA LUSC -0.097; TCGA PAAD -0.092; TCGA SARC -0.108; TCGA STAD -0.15 |
hsa-miR-542-3p | UBE3B | 9 cancers: BRCA; CESC; COAD; ESCA; LIHC; LUAD; PAAD; SARC; STAD | miRanda | TCGA BRCA -0.11; TCGA CESC -0.055; TCGA COAD -0.076; TCGA ESCA -0.093; TCGA LIHC -0.078; TCGA LUAD -0.065; TCGA PAAD -0.112; TCGA SARC -0.087; TCGA STAD -0.098 |
hsa-miR-542-3p | PLEKHB1 | 9 cancers: BRCA; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; UCEC | miRanda | TCGA BRCA -0.178; TCGA HNSC -0.316; TCGA KIRC -0.48; TCGA LGG -0.145; TCGA LUAD -0.185; TCGA PAAD -0.437; TCGA PRAD -0.132; TCGA SARC -0.21; TCGA UCEC -0.135 |
hsa-miR-542-3p | SRRM2 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; PRAD; SARC; STAD | miRanda | TCGA BRCA -0.062; TCGA CESC -0.116; TCGA ESCA -0.126; TCGA HNSC -0.059; TCGA KIRP -0.055; TCGA LUAD -0.081; TCGA PRAD -0.057; TCGA SARC -0.084; TCGA STAD -0.09 |
hsa-miR-542-3p | RALGPS1 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; SARC; UCEC | miRanda; miRNATAP | TCGA BRCA -0.075; TCGA ESCA -0.258; TCGA HNSC -0.54; TCGA KIRC -0.24; TCGA KIRP -0.099; TCGA LUAD -0.169; TCGA PAAD -0.329; TCGA SARC -0.129; TCGA UCEC -0.072 |
hsa-miR-542-3p | ATXN7 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; SARC; STAD | miRanda | TCGA BRCA -0.124; TCGA COAD -0.081; TCGA ESCA -0.222; TCGA HNSC -0.141; TCGA KIRC -0.083; TCGA LUAD -0.066; TCGA PRAD -0.061; TCGA SARC -0.07; TCGA STAD -0.069 |
hsa-miR-542-3p | VSIG10 | 10 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.182; TCGA ESCA -0.198; TCGA HNSC -0.26; TCGA KIRP -0.076; TCGA LGG -0.079; TCGA LIHC -0.247; TCGA LUAD -0.093; TCGA PRAD -0.106; TCGA SARC -0.136; TCGA THCA -0.053 |
hsa-miR-542-3p | MYO5C | 9 cancers: BRCA; ESCA; HNSC; KIRC; LIHC; LUAD; PRAD; SARC; UCEC | miRanda | TCGA BRCA -0.155; TCGA ESCA -0.353; TCGA HNSC -0.651; TCGA KIRC -0.21; TCGA LIHC -0.168; TCGA LUAD -0.156; TCGA PRAD -0.122; TCGA SARC -0.093; TCGA UCEC -0.094 |
hsa-miR-542-3p | PDPK1 | 11 cancers: BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BRCA -0.121; TCGA CESC -0.122; TCGA ESCA -0.156; TCGA HNSC -0.128; TCGA LGG -0.067; TCGA LIHC -0.149; TCGA LUAD -0.095; TCGA LUSC -0.067; TCGA PRAD -0.065; TCGA SARC -0.069; TCGA STAD -0.094 |
hsa-miR-542-3p | IRF6 | 9 cancers: BRCA; CESC; KIRC; LGG; LUAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.09; TCGA CESC -0.242; TCGA KIRC -0.326; TCGA LGG -0.136; TCGA LUAD -0.089; TCGA PRAD -0.108; TCGA SARC -0.821; TCGA THCA -0.108; TCGA UCEC -0.185 |
hsa-miR-542-3p | CLEC16A | 9 cancers: CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; PRAD; UCEC | MirTarget | TCGA CESC -0.071; TCGA COAD -0.066; TCGA ESCA -0.154; TCGA KIRC -0.081; TCGA KIRP -0.071; TCGA LIHC -0.102; TCGA LUAD -0.054; TCGA PRAD -0.056; TCGA UCEC -0.079 |
hsa-miR-542-3p | SAMD10 | 9 cancers: CESC; ESCA; HNSC; KIRP; LIHC; PAAD; PRAD; SARC; UCEC | miRanda | TCGA CESC -0.221; TCGA ESCA -0.174; TCGA HNSC -0.411; TCGA KIRP -0.118; TCGA LIHC -0.274; TCGA PAAD -0.17; TCGA PRAD -0.079; TCGA SARC -0.217; TCGA UCEC -0.182 |
hsa-miR-542-3p | YPEL3 | 9 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; SARC; STAD | miRanda | TCGA CESC -0.126; TCGA HNSC -0.104; TCGA KIRP -0.106; TCGA LGG -0.171; TCGA LIHC -0.098; TCGA LUSC -0.156; TCGA PAAD -0.123; TCGA SARC -0.084; TCGA STAD -0.136 |
hsa-miR-542-3p | KDM4B | 9 cancers: CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; STAD; UCEC | mirMAP | TCGA CESC -0.08; TCGA ESCA -0.1; TCGA HNSC -0.077; TCGA KIRP -0.052; TCGA LGG -0.056; TCGA LIHC -0.121; TCGA LUAD -0.068; TCGA STAD -0.074; TCGA UCEC -0.066 |
hsa-miR-542-3p | TOM1L2 | 9 cancers: COAD; ESCA; HNSC; LGG; LIHC; LUAD; PAAD; SARC; STAD | mirMAP | TCGA COAD -0.168; TCGA ESCA -0.245; TCGA HNSC -0.163; TCGA LGG -0.089; TCGA LIHC -0.112; TCGA LUAD -0.097; TCGA PAAD -0.178; TCGA SARC -0.159; TCGA STAD -0.333 |
Enriched cancer pathways of putative targets